MedPath

The comparison of honey vaginal gel with metronidazole vaginal gel on treatment of recurrent bacterial vaginosis

Phase 2
Conditions
Recurrent bacterial vaginosis.
Other specified inflammation of vagina and vulva
Registration Number
IRCT2016012826244N1
Lead Sponsor
Vice Chancellor Of Research Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
61
Inclusion Criteria

proven recurrent bacterial vaginosis based on the history (of 3 or more than 3 times recurrence of symptoms and the clinical Amsel criteria; women 18-49 years old; married; single spouse; the absence of pregnancy and lactation; signed informed consent to participate in the study; not taking any vaginal medications in last 48 hours; not taking any antibiotics during the last 3 weeks; lack of vaginal intercourse or shower in the last 24 hours; no smoking; no alcohol consumption ; not taking any anticoagulants such as Coumadin and disulfiram; there is not any known medical condition like diabetes; blood Dyskrazy; thyroid disease and liver disease history; do not use IUD.
Exclusion criteria: patient's request ; the medication is not used for more than once; no condom use during the course of treatment; Menstruation .

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Recurrent bacterial vaginosis. Timepoint: Before treatment and after treatment. Method of measurement: Observation.
Secondary Outcome Measures
NameTimeMethod
Recurrent bacterial vaginosis treatment. Timepoint: 7 and 30 days after treatment. Method of measurement: observation.
© Copyright 2025. All Rights Reserved by MedPath